CHEMED CORP·4

Oct 22, 5:27 PM ET

Wherley Joel L 4

4 · CHEMED CORP · Filed Oct 22, 2025

Insider Transaction Report

Form 4
Period: 2025-10-21
Wherley Joel L
CEO - Vitas Healthcare
Transactions
  • Award

    Stock Option (right to buy with tandem tax withholding)

    2025-10-21$443.79/sh+17,476$7,755,67432,819 total
    Exercise: $443.79Exp: 2030-10-21Capital Stock (17,476 underlying)
Footnotes (1)
  • [F1]Vesting in three equal annual installments commencing 10/21/2026

Documents

1 file
  • 4
    ownership.xmlPrimary

    4